Summary
Acobiom is a biotechnology company that specializes in biomarker discovery and development of innovative diagnostics. The company undertakes the discovery of RNA/DNA biomarkers, which finds application in the areas of disease detection and classification, patient stratification, companion diagnosis and disease prognosis. It develops diagnostics centered on personalized medicine and precision medicine applications. Acobiom’s also offers services such as sequencing, next generation sequencing (NGS), bioinformatics, biostatistics, and real time PCR, among others. Its technology platforms include qRT-PCR, gene expression and bioinformatics. The company offers products in the areas of personalized medicines, medical products, leukemia and gemcitest. Acobiom is headquartered in Montpellier, France.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Acobiom
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Acobiom Company Overview 4
Acobiom Company Snapshot 4
Acobiom Pipeline Products and Ongoing Clinical Trials Overview 4
Acobiom – Pipeline Analysis Overview 7
Acobiom - Key Facts 7
Acobiom - Major Products and Services 8
Acobiom Pipeline Products by Development Stage 9
Acobiom Pipeline Products Overview 11
Biomarker Test - Hantavirus 11
Biomarker Test - Hantavirus Product Overview 11
Companion Diagnostic Assay - Mastinib 12
Companion Diagnostic Assay - Mastinib Product Overview 12
Companion Diagnostic Assay - Prostate Cancer 13
Companion Diagnostic Assay - Prostate Cancer Product Overview 13
Companion Diagnostic Test - Alzheimer's Disease 14
Companion Diagnostic Test - Alzheimer's Disease Product Overview 14
Companion Diagnostic Test - Breast Cancer 15
Companion Diagnostic Test - Breast Cancer Product Overview 15
Companion Diagnostic Test - Lung Cancer 16
Companion Diagnostic Test - Lung Cancer Product Overview 16
Companion Diagnostic Test - Triple Negative Breast Cancer 17
Companion Diagnostic Test - Triple Negative Breast Cancer Product Overview 17
Diagnostic Assay - Chronic Myelomonocytic Leukemia 18
Diagnostic Assay - Chronic Myelomonocytic Leukemia Product Overview 18
Diagnostic Test - Dengue 19
Diagnostic Test - Dengue Product Overview 19
Diagnostic Test - Leishmania 20
Diagnostic Test - Leishmania Product Overview 20
GemciTest 21
GemciTest Product Overview 21
Acobiom - Key Competitors 22
Acobiom - Key Employees 23
Acobiom - Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Acobiom, Recent Developments 25
Nov 03, 2012: Skuldtech And AB Science Announce Identification Of New Predictive Markers For Pancreatic Cancer Survival Associated With Masitinib Treatment 25
Appendix 26
Methodology 26
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Tables
Acobiom Pipeline Products and Ongoing Clinical Trials Overview 4
Acobiom Pipeline Products by Equipment Type 5
Acobiom Pipeline Products by Indication 6
Acobiom, Key Facts 7
Acobiom, Major Products and Services 8
Acobiom Number of Pipeline Products by Development Stage 9
Acobiom Pipeline Products Summary by Development Stage 10
Biomarker Test - Hantavirus - Product Status 11
Biomarker Test - Hantavirus - Product Description 11
Companion Diagnostic Assay - Mastinib - Product Status 12
Companion Diagnostic Assay - Mastinib - Product Description 12
Companion Diagnostic Assay - Prostate Cancer - Product Status 13
Companion Diagnostic Assay - Prostate Cancer - Product Description 13
Companion Diagnostic Test - Alzheimer's Disease - Product Status 14
Companion Diagnostic Test - Alzheimer's Disease - Product Description 14
Companion Diagnostic Test - Breast Cancer - Product Status 15
Companion Diagnostic Test - Breast Cancer - Product Description 15
Companion Diagnostic Test - Lung Cancer - Product Status 16
Companion Diagnostic Test - Lung Cancer - Product Description 16
Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status 17
Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description 17
Diagnostic Assay - Chronic Myelomonocytic Leukemia - Product Status 18
Diagnostic Assay - Chronic Myelomonocytic Leukemia - Product Description 18
Diagnostic Test - Dengue - Product Status 19
Diagnostic Test - Dengue - Product Description 19
Diagnostic Test - Leishmania - Product Status 20
Diagnostic Test - Leishmania - Product Description 20
GemciTest - Product Status 21
GemciTest - Product Description 21
Acobiom, Key Employees 23
Glossary 27
List of Figures
Acobiom Pipeline Products by Equipment Type 5
Acobiom Pipeline Products by Development Stage 9
